Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.830
+0.040 (2.23%)
At close: Dec 20, 2024, 4:00 PM
1.880
+0.050 (2.72%)
After-hours: Dec 20, 2024, 7:03 PM EST
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $399.27 million as of December 20, 2024. Its market cap has increased by 81.16% in one year.
Market Cap
399.27M
Enterprise Value
468.45M
1-Year Change
81.16%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $399.27M, a decrease of -18.20%. That is a compound annual growth rate of -1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 399.30M | 70.93% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Community Health Systems | 402.48M |
| Arcturus Therapeutics Holdings | 401.98M |
| National Research | 400.74M |
| Monte Rosa Therapeutics | 399.95M |
| KalVista Pharmaceuticals | 399.79M |
| Enhabit | 387.19M |
| Alpha Teknova | 385.95M |
| Allogene Therapeutics | 385.80M |